Why is Mounjaro so hard to get?

Novo Nordisk's popular weight-loss drug Wegovy is difficult for patients to find right now—as are other, similar GLP-1 drugs such as Eli Lilly's Mounjaro—due to supply shortages, massive demand, and restrictions from drugmakers on who is allowed to use the medications.

advisory.com - Why it's so hard to find weight-loss drugs right now - Advisory Board

How can I intensify phentermine?

Cardio and Weights Could Boost Your Phentermine Plan Cardio and lifting weight will help you tone your body. By toning your body, you will create...

Last updated Nov 1, 2018

Why do I feel thinner but weigh more?

Muscle is denser than fat, and as it is more compact within your body, as you gain muscle mass, you end up looking thinner, no matter your physical...

Last updated Oct 11, 2020

Promotion

A spike in demand

GLP-1 drugs mimic a hormone called glucagon-like peptide-1 to target areas of the brain that regulate appetite and food intake. In 2021, FDA approved Wegovy for the treatment of obesity after a clinical trial showed it helped patients lose an average of 15% of their body weight over 68 weeks. Mounjaro has also been approved by FDA but only to treat Type 2 diabetes. However, many patients are finding it difficult to access these drugs, in part because of supply shortages. "Demand for these new agents has been unlike anything I've ever seen in my time in medicine," said Michael Albert, a physician specializing in weight-loss treatment at Accomplish Health. According to Albert, many of his patients started asking about Wegovy after hearing about it on Facebook and TikTok. According to Novo Nordisk CEO Lars Fruergaard Jørgensen, it took just five weeks for the volume of Wegovy prescriptions to hit the same weekly levels it took Novo Nordisk's old obesity drug, Saxenda, four years to reach. "It's a completely different ballgame that we're in," said Ambre Brown Morely, Novo Nordisk's VP of media and digital communication. Novo Nordisk didn't anticipate the level of demand it ended up seeing and, as a result, has been forced to allocate Wegovy to only patients who have already started taking it. "We should have forecasted better, which we did not," Jørgensen said. "Had we forecasted that, we would have built a different supply chain." Jørgensen said the company has increased its capacity and plans a "relaunch" of Wegovy early next year, which should fulfill all orders for the drug.

Restrictions on who can take weight-loss drugs

GLP-1 drugs have also been hard to come by because of restrictions from drugmakers on who doctors can prescribe the drugs to. Eli Lilly, for example, allows only patients who confirm a type 2 diabetes diagnosis to receive Mounjaro. But many patients with clinical obesity have been turning to the drug as one of the few treatment options available to them. While it's understandable that Eli Lilly would target Mounjaro to the people it's intended for, the situation is "unfair to everybody," said W. Scott Butsch, director of obesity medicine in the Bariatric and Metabolic Institute at the Cleveland Clinic. "It's unfair to people who have obesity because there's a drug that actually can very well help them and there's a provider who wants to treat obesity, yet does not have access to a very reasonable treatment." Butsch added that, while patients with diabetes have some other medications available to them, patients with obesity have few other treatment options. In addition, there's a large overlap between diabetes and obesity, and patients with obesity have a high risk of eventually developing diabetes, according to Beverly Tchang, an endocrinologist and assistant professor of clinical medicine at Weill Cornell Medicine. "Obesity can lead to diabetes, diabetes can lead to obesity," she said. "They're very much intertwined, and to treat one but not the other seems inequitable." It seems that people "want to 'save the medication' for the people who 'need it,' and I understand that sentiment," Tchang added. But "we need to look at obesity as its own disease that is equally deserving of treatment." (Loftus/Roland, Wall Street Journal, 12/4; Chen, STAT, 12/7)

How do I lose my stomach pouch?

6 Simple Ways to Lose Belly Fat, Based on Science Avoid sugar and sugar-sweetened drinks. Foods with added sugars are bad for your health. ... Eat...

Last updated Dec 27, 2020

Can i take phentermine and not exercise?

Phentermine should NOT be used as a substitute for proper diet or exercise. For maximum effects, it must be used in conjunction with a reduced-...

Last updated Jun 1, 2022

Promotion

How can I check my kidney at home?

A quick look at the best at-home kidney test kits Best blood sample test: LetsGetChecked Kidney Test. Best blood test for detailed results:...

Last updated Oct 17, 2019

Who Cannot take ashwagandha?

Talk to a doctor before using ashwagandha if you have any health conditions, including cancer, diabetes, thyroid problems, bleeding disorders,...

Last updated Jun 14, 2018

Promotion

How to lose weight for free?

11 Proven Ways to Lose Weight Without Diet or Exercise Chew Thoroughly and Slow Down. ... Use Smaller Plates for Unhealthy Foods. ... Eat Plenty of...

Last updated May 16, 2019

Learn More »

Promotion

How much weight do you lose before face changes?

“Women and men of average height need to gain or lose about three and a half and four kilograms, or about eight and nine pounds, respectively, for...

Last updated Mar 28, 2021